This patient was born full-term weighing 6 lb 9 oz through spontaneous vaginal delivery without complications to a mother, who was 34 years old, G3P2. APGAR scores were 10. Development was initially normal, as early milestones were achieved as expected. Then, at the age of 7 months, just 9 hours after her third DPT vaccination, she developed a fever of 40°C and experienced a generalized tonic-clonic seizure that stopped after 3 minutes and recurred shortly after, continuing for another hour, ending following diazepam treatment in the emergency room. Workup for systemic and central nervous system infections were negative, as was the CT of the brain for structural abnormalities. She returned to her baseline level of functioning within 8 hours. A routine EEG done the next morning showed no abnormalities, and no medications were initiated. She continued at her baseline level of functioning and development, but then at 9 months of age, she developed a flu-like illness, became febrile to 39.4°C, and suffered another generalized tonic-clonic seizure lasting about 10 minutes. Within the next few months, she began to develop subtle myoclonic jerks and appeared to have prolonged 1-3-minute trance-like spells and, about the same time, her developmental milestones began to lag. It was not until 14 months of age that she began to cruise.
and severity varying day-to-day. Despite treatment with the ketogenic diet and multiple AED combinations, she continued to experience atypical absence, complex partial, atonic and generalized tonic-clonic seizures with nearly the same frequency. Her family history is positive only for a brother who had a febrile seizure at the age of 15 months.
Current Status
When seen at the age of 15, she was wheelchair bound. She exhibited severe ataxia of all limbs, moderate spasticity, and hyperreflexia. There was no language output, although she would still follow simple commands, and laugh or smile occasionally in the appropriate context. Brain MRI showed only diffuse atrophy and scattered white matter lesions (Figure 1) . A recent EEG showed continued background slowing, with a posterior dominant rhythm of 7.5 Hz and frequent epileptiform interictal discharges. Over the years, EEG monitoring recorded frequent atypical absence and complex partial seizure activity ( Figure 2 ). She takes levetiracetam 2000 mg bid, felbamate 1200 mg tid, and uses midazolam nasal spray PRN (off-label, not FDA-approved) for prolonged seizures.
Discussion
The clinical presentation of status epilepticus during a febrile condition and subsequent development of refractory epilepsy is in keeping with severe myoclonic epilepsy of infancy (SMEI), also known as Dravet syndrome. She exhibited myoclonic jerks early in life, but these disappeared with age. Among the most striking features of this case were the significant motor and language deficits that progressed through childhood, occurring in the more severe cases. This syndrome is associated with genetic defects of SCN1A. This patient was tested several years ago, which identified a new mutation of the SCN1A gene that has yet to be well characterized.
Her medication regimen evolved over years, with highdose levetiracetam and felbamate appearing to provide more days without seizures per month than others and without causing excessive drowsiness or irritability. Intranasal midazolam is not FDA-approved, though clinical trials in adults (1) and children (2) mide, 3) open-label trials of levetiracetam, topiramate, and 4) a prospective trial of bromide and a retrospective trial using the ketogenic diet. All demonstrated some efficacy but in small numbers of patients. There is also a retrospective study of vagal nerve stimulation in 8 patients that showed long-term seizure reductions (4) .
